WASF3 Knockdown Sensitizes Gastric Cancer Cells to Oxaliplatin by Inhibiting ATG12-Mediated Autophagy.

CONCLUSIONS: Our analysis demonstrates WASF3 targeting is a new potential therapeutic strategy for gastric cancer.
PMID: 32359534 [PubMed - in process]

Source: The American Journal of the Medical Sciences - April 30, 2020 Category: General Medicine Authors: Nie Y, Liang X, Liu S, Guo F, Fang N, Zhou F Tags: Am J Med Sci Source Type: research